Uzan A - Search Results

1

Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis.

André P, Hamaud P, Bal dit Sollier C, Drouet V, Garfinkel LI, Uzan A, Caen JP, Drouet LO. André P, et al. Among authors: uzan a. Thromb Res. 1996 Jul 15;83(2):127-36. doi: 10.1016/0049-3848(96)00113-2. Thromb Res. 1996. PMID: 8837311

2

Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor.

Bara L, Bloch MF, Zitoun D, Samama M, Collignon F, Frydman A, Uzan A, Bouthier J. Bara L, et al. Among authors: uzan a. Thromb Res. 1993 Mar 1;69(5):443-52. doi: 10.1016/0049-3848(93)90233-e. Thromb Res. 1993. PMID: 8388583 Clinical Trial.

3

Enoxaparin (Clexane, Lovenox), a low molecular weight heparin, enhances t-PA-induced coronary thrombus lysis in anesthetized dogs without inducing hypocoagulability.

Mestre M, Uzan A, Sedivy P, Cavero I. Mestre M, et al. Among authors: uzan a. Thromb Res. 1992 May 1;66(2-3):191-206. doi: 10.1016/0049-3848(92)90189-h. Thromb Res. 1992. PMID: 1329253

4

Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma-chain carboxy terminal peptides.

Hantgan RR, Endenburg SC, Cavero I, Marguerie G, Uzan A, Sixma JJ, de Groot PG. Hantgan RR, et al. Among authors: uzan a. Thromb Haemost. 1992 Dec 7;68(6):694-700. Thromb Haemost. 1992. PMID: 1287884

5

Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide.

Saelman EU, Hese KM, Nieuwenhuis HK, Uzan A, Cavero I, Marguerie G, Sixma JJ, de Groot PG. Saelman EU, et al. Among authors: uzan a. Arterioscler Thromb. 1993 Aug;13(8):1164-70. doi: 10.1161/01.atv.13.8.1164. Arterioscler Thromb. 1993. PMID: 8343490

6

Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis.

Mestre M, Clairefond P, Mardiguian J, Trillou M, Le Fur G, Uzan A. Mestre M, et al. Among authors: uzan a. Thromb Res. 1985 May 15;38(4):389-99. doi: 10.1016/0049-3848(85)90137-9. Thromb Res. 1985. PMID: 4012669

7

Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers.

Laforest MD, Colas-Linhart N, Guiraud-Vitaux F, Bok B, Bara L, Samama M, Marin J, Imbault F, Uzan A. Laforest MD, et al. Among authors: uzan a. Br J Haematol. 1991 Feb;77(2):201-8. doi: 10.1111/j.1365-2141.1991.tb07978.x. Br J Haematol. 1991. PMID: 1848441

8

[Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169)].

Uzan A, Clairefond P, Mardiguian J, Trillou M, Le Fur G, Mestre M. Uzan A, et al. Ann Pharm Fr. 1985;43(6):539-46. Ann Pharm Fr. 1985. PMID: 3838029 French. No abstract available.

9

PK 10139 and quinidine: interactions with digoxin concentrations in rats and dogs.

Rougeot C, Jozefczak C, Mestre M, Le Fur G, Uzan A. Rougeot C, et al. Among authors: uzan a. J Pharm Pharmacol. 1984 May;36(5):347-9. doi: 10.1111/j.2042-7158.1984.tb04393.x. J Pharm Pharmacol. 1984. PMID: 6145779

10

1-[4-(2-ter-butyl-quinolyl)]-3-(4-piperidyl)propanol (PK 10139): a new potent and long-acting antiarrhythmic agent.

Mestre M, Bouetard G, Le Fur G, Renault C, Gueremy C, Uzan A. Mestre M, et al. Among authors: uzan a. J Pharmacol Exp Ther. 1983 Apr;225(1):158-63. J Pharmacol Exp Ther. 1983. PMID: 6834268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters